Login / Signup

Continuous use of antithrombotic medications during peri-endoscopic submucosal dissection period for colorectal lesions: A propensity score matched study.

Keisuke KawasakiTakehiro TorisuMotohiro EsakiMakoto EizukaShinichiro KawatokoTomo KumeiMinami HiraiMasahiro KondoShin FujiokaYuta FuyunoYuichi MatsunoJunji UmenoTomohiko MoriyamaTakanari KitazonoTamotsu SugaiTakayuki Matsumoto
Published in: Journal of gastroenterology and hepatology (2023)
Continuation of antithrombotic medications during the peri-colorectal ESD period increases the risk of bleeding. However, the continuation may be acceptable under careful monitoring for post-ESD bleeding.
Keyphrases
  • endoscopic submucosal dissection
  • atrial fibrillation